Navigation Links
K-V Pharmaceutical Company Engages BDO USA, LLP as Independent Registered Accountants
Date:8/3/2010

der Part I, Item 1A – "Risks Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2009 and referred to in Part II, Item 1A – "Risk Factors" in the Form 10-Q, as supplemented by the Company's subsequent SEC filings.  

Further, any forward-looking statement speaks only as of the date on which it is made and the Company is under no obligation to update any of the forward-looking statements after the date of this press release.  New factors emerge from time-to-time, and it is not possible for the Company to predict which factors will arise, when they will arise and/or their effects.   In addition, the Company cannot assess the impact of each factor on its future business or financial condition or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.


'/>"/>
SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. CORRECTED: Ampio Pharmaceuticals Announces Completion of Negotiations for Acquisition of DMI BioSciences, Inc.
2. Vanda Pharmaceuticals to Announce Second Quarter 2010 Financial Results on August 5, 2010
3. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010
4. Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patients
5. China BCT Further Expands its Footprint by Opening 12 New Retail Pharmaceutical Stores
6. Amira Pharmaceuticals Hits Two Development Milestones Related to FLAP Inhibitor Program
7. Lialda(R) - Shire Files Suit Against Cadila Healthcare Limited, Doing Business as Zydus Cadila and Zydus Pharmaceuticals (USA), Inc.
8. Viscira Delivers Key Presentation to Pharmaceutical Marketing Professionals at Leading Digital Industry Conference
9. Biostar Pharmaceuticals, Inc. Appoints New Chief Financial Officer
10. United Therapeutics and Lees Pharmaceutical Sign Remodulin Distribution Agreement for China
11. Angiotech Pharmaceuticals Announces Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014   Sequenom, Inc. ... company that provides innovative genetic analysis solutions, and ... esoteric laboratory services in the United States ... prenatal testing patents and applications. "We have ... and patient care, and we welcome the opportunity to ...
(Date:7/29/2014)... particle be separated from its properties? On July 29, ... results of the first Cheshire Cat experiment, separating a ... in Orange, CA, and Vienna University of Technology. , ... grin," thought Alice in Wonderland, "but a grin without ... saw in my life!" Alice,s surprise stems from her ...
(Date:7/29/2014)... has created a new way of manufacturing microstructured ... made by self-assembly of carbon nanotubes, could exhibit ... mechanical stiffness and strength, or the ability to ... have demonstrated that mechanical forces can be used ... and that we can independently control the ...
(Date:7/29/2014)... YORK , July 29, 2014  Pomerantz LLP ... Laboratories, Inc. ("Impax" or the "Company") (NASDAQ: IPXL).  Such ... at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ... of its officers and/or directors have violated Sections 10(b) ... On July 29, 2014, Impax Laboratories, ...
Breaking Biology Technology:Sequenom Enters Into License Agreement With Mayo Medical Laboratories 2Sequenom Enters Into License Agreement With Mayo Medical Laboratories 3Sequenom Enters Into License Agreement With Mayo Medical Laboratories 4The quantum Cheshire cat: Scientists separate a particle from its properties 2The quantum Cheshire cat: Scientists separate a particle from its properties 3The quantum Cheshire cat: Scientists separate a particle from its properties 4A new way to make microstructured surfaces 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Impax Laboratories, Inc. - IPXL 2
... 14, 2010 ... ... var shortURL = ... so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; ...
... DIEGO, Sept. 14 Stemedica Cell Technologies, Inc., a ... announced today that it has completed its proprietary master ... cell bank was manufactured in accordance with FDA Good ... all the necessary safety testing required by the FDA ...
... Regenicin™, Inc. (OTC Bulletin Board: ... today that John J. Weber, the former highest ranking ... ("Fujifilm USA"), has agreed to join the company as ... Chief Financial Officer.  Weber brings over 20 years of ...
Cached Biology Technology:NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 2NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 3NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 4NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 5NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 6NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 7Stemedica Announces Completion of Clinical Stem Cell Master Bank 2Former Fujifilm Medical Systems USA Executive John J. Weber Agrees to Join Regenicin™ as a Member of Its Board of Directors and Interim CFO 2
(Date:7/30/2014)... develop into a multitude of cells types. Researchers would like ... types of mature cells that make up the organs and ... to be long chains of sugars that dangle from proteins ... University of California, San Diego, has created synthetic molecules that ... more easily manipulated to direct the process, they report in ...
(Date:7/30/2014)... the journal Scientific Reports , published by ... found that while global temperature is indeed increasing, so ... while each year,s average hottest and coldest temperatures will ... within a wider range of potential high and low ... that even as overall temperatures rise, we may still ...
(Date:7/29/2014)... science, researchers sometimes need to get back to ... that to study the impacts of the bumphead ... ecosystems at two remote locations in the central ... and computer simulation, McCauley, an assistant professor in ... and his colleagues sought to understand whether the ...
Breaking Biology News(10 mins):Big data confirms climate extremes are here to stay 2Underwater elephants 2Underwater elephants 3
... Dr. Gregory King, professor and chair of the Department ... the recipient of the 2009 Craniofacial Biology Research Award, ... Research (IADR) at its 87th General Session & Exhibition ... King began his undergraduate studies in Biology at Brown ...
... sinks have on rising carbon emissions is gradually weakening, ... grasslands and oceans are absorbing carbon dioxide (CO 2 ... are not keeping pace with rapidly rising emissions," says ... Dr Mike Raupach. "While these natural CO 2 ...
... in Newark and the surrounding area, NJIT has received a ... This grant renews the Foundation,s valuable support ... about nutrition, physical fitness and healthy lifestyles. At NJIT, the ... Education in Greater Newark, a partnership of NJIT, Rutgers University ...
Cached Biology News:Carbon sinks losing the battle with rising emissions 2
Anti-BAR Immunogen: Peptide of aa 3-21 from human Bar Available Date: 38226...
... the HECT protein, E6-AP and ... suggests that this E2 is ... of non-""N-end rule"" protein substrates ... proteins as well as the ...
Anti-Mouse D011.10 TCR, Biotin (Clone KJ1-26) (mouse IgG2a)...
Reacts with methylated DNA from plants and vertebrates...
Biology Products: